Moderna-Merck vaccine cuts odds of skin cancer recurrence in half, study finds
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.
https://www.cbsnews.com/news/merck-moderna-vaccine-skin-cancer-melanoma